BOD Australia Ltd (BOD)

Snapshot

BOD's Principal Activity is the development and manufacture of CBD and hemp products for consumer markets in Australia and United Kingdom as well as the development, manufacture and distribution of therapeutics medicinal cannabis products based on Good Manufacturing Practice (GMP) certified cannabis extracts for medical markets.

Announcements

Corporate Overview

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date	Amount	Franking	Gross	Type	Payable
No dividends paid.

Show All

See Upcoming Dividends for all ASX companies.

Directors & Management

Name	Title	Since	Bio
Mr Johannes (Hanno) Jacobus Cappon	Non-Executive Director	Jul 2021	Mr Johannes (Hanno) Jacobus Cappon Non-Executive Director Mr Cappon has experience in biochemistry, nutrition, health and innovation. He has a background in chemistry, life sciences, nutrition and health innovation and developing new consumer and healthcare solutions for commercialization. Mr Cappon is currently Chief Technology Officer at H&H, a position which he has held since January 2021. Mr Cappon's previous senior roles with international companies include VP R&D Nutritionals & Digestive Health at Bayer Consumer Health, Switzerland, as well as VP R&D Nutricia Medical Nutrition at multinational food company Danone Nutricia, Netherlands, amongst others.
Mr Mark Masterson	Non-Executive Director,Non-Executive Chairman	Nov 2019	Mr Mark Masterson Non-Executive Director,Non-Executive Chairman Mr Masterson has two decades of experience in the pharmaceutical and healthcare sectors. He began his career with Johnson & Johnson before joining Abbott Laboratories (NYSE: ABT) where he held senior positions. Mark also held the role of CEO with I-MED. Following the acquisition of I-MED, he was appointed Chairman of Medicines Australia.
Mr Akash Bedi	Non-Executive Director	Jul 2019	Mr Akash Bedi Non-Executive Director Mr Bedi is Group Senior Director of Strategy and Corporate Affairs at H&H Group. He is based in Hong Kong and is responsible for leading H&H Group's strategy and business development including mergers and acquisitions, and strategic investments for NewH2. He has experience in investing in global start-ups and companies with technologies and businesses that are of strategic importance to H&H Group. Akash has experience in multicultural and global environments. Prior to joining H&H Group, he was a Director of Global Consumer and Retail for HSBC for over a decade. During this time he worked on a number of acquisitions in North America, London and Asia. He is Director of Else Nutrition Holdings, Inc.
Mr Stephen Kelly	Company Secretary	Sep 2018
Mr George Livery	Non-Executive Director	Sep 2018	Mr George Livery Non-Executive Director Mr Livery has over 25 years' experience in senior roles domestically and internationally. His last seven years as director of strategy and corporate development at Swisse Wellness Group. In addition, George's executive experience is in positions across multiple other industries including the role of chief executive officer at Village Cinemas Australia, chief operating officer of Village International, commercial director at Hoyts Limited, and director of operations and marketing (non-academic services) at the University of Sydney. George is migration agent, not- for-profit advisor, corporate board strategist, investor and mentor.
Mr Simon Thomas O'Loughlin	Non-Executive Director	Oct 2016	Mr Simon Thomas O'Loughlin Non-Executive Director Mr O'Loughlin is the founder of O'Loughlins Lawyers. He has experience in the corporate and commercial law fields while practising in Sydney and Adelaide. Simon has experience and involvement with companies in the industrial and resources sectors. He is a former Chairman of the Taxation Institute of Australia (SA Division) and Save the Children Fund (SA Division). He is Director of Chesser Resources Limited, Petratherm Limited, Kibaran Resources Limited, Food Revolution Group Limited, Goldminex Limited, Oklo Resources Limited, Crest Minerals Limited, Reproductive Health Science Limited, King Solomon Mines Limited, Lawson Gold Limited, Gooroo Ventures Limited, ARC Exploration Limited and WCP Resources Limited.
Ms Joanne (Jo) Patterson	Chief Executive Officer,Executive Director	Oct 2016	Ms Joanne (Jo) Patterson Chief Executive Officer,Executive Director Ms Patterson has over 20 years' experience in business and corporate strategy in Australia and international markets. She has developed a number of businesses from start-up as well as driving established organisations towards growth and merger trajectories. Jo has held multiple CEO and Managing Director roles over her career.
Craig Weller	Chief Operating Officer	N/A

Show All

Director Interests

Director	Last Notice	Direct Shares	Indirect Shares	Options	Convertibles
Johannes (Hanno) Cappon	20/07/2021	0	N/A	N/A	N/A
Akash Bedi	23/12/2020	0	N/A	1,000,000	N/A
George Livery	16/10/2020	300,000	20,000	2,800,000	N/A
Mark Masterson	30/06/2020	N/A	441,176	750,000	N/A
Joanne (Jo) Patterson	30/06/2020	N/A	6,550,000	N/A	N/A
Simon O'Loughlin	30/06/2020	N/A	1,160,000	500,000	N/A

Show All

Top 20 Shareholders

About the Data

Name	Shares	Capital
New H2 Limited	14,864,865	16.27%
HSBC Custody Nominees (Australia) Limited	8,655,677	9.47%
Health And Beauty Enterprise Pty Limited	5,750,000	6.29%
Noir Ted Pty Ltd	4,852,329	5.31%
AWJ Family Pty Ltd	4,445,346	4.27%
J P Morgan Nominees Australia Pty Limited	3,319,960	3.63%
GP Securities Pty Ltd	2,143,572	2.35%
Citicorp Nominees Pty Limited	1,752,115	1.92%
Calama Holdings Pty Ltd	1,505,000	1.25%
Jimbzal Pty Ltd	1,360,000	1.27%
BNP Paribas Nominees Pty Ltd	1,115,300	1.22%
Yoix Pty Ltd	1,010,000	1.11%
Twenty Ten Enterprises Pty Ltd	960,277	1.05%
Ms Suzanne Taylor	897,671	0.98%
JGC Patterson Pty Ltd	800,000	0.88%
AWJ Family Pty Ltd (I)	716,084	0.78%
CS Third Nominees Pty Limited	620,100	0.68%
National Nominees Limited	582,218	0.64%
Bond Street Custodians Limited	441,176	0.48%
Baker Cook Advisory Pty Ltd	750	0.82%

Show All

Shareholder Distribution

As reported in the most recent Annual Report.

The most recent Annual Report didn't contain Shareholder Distribution data.

Substantial Shareholders

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Share Price History

Date	Close	Change	%Chg	Open	High	Low	Volume	Turnover

Full Month

Historical Data

Year	Closing Price	Last Trade
No Financial Year End data available

BOD Historical Price Data (CSV)

Up to 20 years of EOD share price history

Sign up to Download

You must be logged in to access this feature. Please sign up for free or login.